INTRODUCTION
Lyophilized live plague vaccine derived from an attenuated Pasteurella pestis strain EV (this will be abbreviated to EV) is in the world-wide use these days. In countries such as USSR and Peoples' Democratic Republic of China, where plague epidemics have been controled, EV has been adopted as the standard live vaccine.
Even in the USA where the minimum requirements for killed plague vaccine have been established since 1945, EV live vaccine has been inoculated into military personel going to South Vietnam where plague is prevailing. This attenuated strain, isolated in Madagascar by Girard and Robic (1936) , is differentiated from other attenuated vaccine strains (MII40, Twijidej) by the presence of VW antigens (Burrows and Bacon, 1956 ) commonly occurring in virulent strains. 
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Most studies on live plague vaccine have been made using guinea pigs as an experimental animal (Korobkova, 1956) . The Soviet standard of production and control of live antiplague vaccine also adopted guinea pigs as the experimental animal.
However, guinea-pigs and rabbits are known as animal species which withstand extremely large doses of the plague toxin (Pollitzer, 1954 ). An anxiety remains that the control tests (safety test and potency test) using such exceptionally toxin-resistant experimental animals might not ensure the applicability of the vaccine for human beings, that are thought to be toxin-sensitive (Pollitzer, 1954) . If a control test using mice became possible, we might be able to administer the controled vaccine to human beings without any anxiety, because mice are another extreme of animals being sensitive to plague toxin. In addition, the economical reason makes mice much superior to guinea pigs as the experimental animal for the control test.
In the comparative study of response to EV made in our laboratories, we found that the guinea pig and the mouse react differently to this strain.
Though this difference had been expected from a higher sensitibity possessed by mice than by guinea pigs to plague murine toxin, we intended to make a more precise analysis of this reaction in mice to provide fundamental bases for further studies on the virulence and immunogenesis of plague bacilli. Besides, this kind of study appeared to be essential before this live vaccine is actually administered to Japanese people. The main purpose of this study was to examine the safety and protective potency of EV vaccine which will possibly be used in Japan in case of accidental invasion of this disease.
This report deals with our observations on the partial virulence of EV strain to mice, mainly on histopathological changes in the organs, and also its relation to the immunogenesis of mice against plague. small number of EV. In this way, EV survived at the injected site for as long as one week though decreasing gradually in number.
MATERIALS AND METHODS

Strains
The tendency of the strain to invade the internal organs was explained by the detection of EV from the spleen and liver of 2 of 3 mice already on the first day after the injection.
During the second to fifth days after the injection, not all but some mice allowed EV to grow from the homogenate of the spleen, liver and/or kidneys. These results coincided with the findings in the histopathological examinations. We repeated experiments using EV originating from this NIIEG line having different histories.
It was concluded that the survival in the mouse organs is a tendency common to all lines of EV, except that less invasion into the internal organs was observed in the other experiments using EV 51 strain kindly supplied from the USA Army.
Relationship between Toxicity and Protective Potency of EV Live Vaccine in Mice The spleen, liver, and lungs were removed every day for the observation of histopathological changes.
In the following, the detailed description is presented in order to know the circumstantial character of this human vaccine strain.
The detected changes are summarized at the end of this section.
Lung:
We found no consistent histopathological changes in the lungs of the mice killed at one day intervals.
Slight hyperaemia at alveolar septae was seen on the sections of the 2nd and the 4th days after the injection.
Perivascular cellular infiltration was found on the sections of the 10th and the 12th days after the injection ; the former was accompanied by scattering of perivascular and penbronchial connective tissue and the latter consisted of lymphocytes, monocytes and polymorphonuclear leucocytes.
In the sections of the 15th day, we found the cellular infiltration both in the alveolar septae and the perivascular region. In the sections of the 16th day, only the scattering of peribronchial connective tissues was found.
Since no change was found on the sections of the other days, the changes mentioned above are not regarded as specific to the injection of EV. The liver reacted to the injection of EV and developed most remarkable histopathological changes.
Beginning with a slight cellular infiltration in the liver parenchyma and the perivascular regions on the 1st day after the injection, successive changes were observed as infiltration of round cells all over, infiltration of reticuloendothelial cells in the perivascular regions within Glissons' sheaths and slight hyperplasia of Kupffers' cells on the 2nd day after the injection ; granulomas in the marginal regions of Glissons' sheath and perivascular regions, and occasional slight cell infiltration in liver parenchyma on the 3rd day ; large and small parenchymal and perivascular granulomas, partial hyperplasia of liver capsule, a limited area of necrosis under the liver capsule, and occasional slight hyperaemia and fatty degeneration on the 4th day ; generally slight infiltration of reticuloendothelial cells within the Glissons' sheaths on the 5th day ; infiltration of lymphocytes, polymorphonuclear leucocytes and plasma cells, parenchyma all over the liver and within Glissons' sheaths, and slight hyperplasia of Kupffers' cells on the 6th day ; frequent but slight cellular infiltration and hyperplasia of the reticuloendothelial system on the 7th day ; slight cellular infiltration in the liver parenchyma and perivascular regions on the 8th day ; granulomas in the liver parenchyma and in the regions surrounding Glissons' sheaths and very severe cellular infiltration in these regions on the 9th day ; slight perivascular granulomas of liver parenchyma, cellular infiltration in the parenchyma and in the perivascular region within Glissons' sheaths, remarkable perivascular necrosis all over the liver and localized hyperaemia and fatty degeneration under the liver capsule on the 10th day ; slight granulomas in the liver parenchyma, cellular infiltration in the penvascular regions within liver parenchyma on the 11th day ; perivascular granu- perivascular cellular infiltration, and occasional perivascular necrosis on the 13th day ; perivascular necrosis surrounded by granulomas in remarkably wide regions and cellular infiltration in the liver parenchyma and Glissons' sheaths on the 14th day ; cellular infiltration in the parenchyma and the surrounding region of Glissons' sheaths, perivascular necrosis and slight granulomas in the perivascular regions of liver parenchyma on the 15th day ; generally slight cellular infiltration in the liver parenchyma and Glissons' sheaths on the 16th day ; cellular infiltration all over the liver parenchyma and slight perivascular granulomas on the 17th day ; and slight cellular infiltration in the liver parenchyma on the 18th day.
Thus cellular infiltration in the perivascular regions, liver parenchyma and Glissons' sheaths was followed by the formation of granulomas in the perivascular regions and the marginal regions of Glissons' sheaths on the 3rd day after the injection.
Such granulomas were observed mainly in the perivascular regions as seen in the changes on the 3rd, 4th, 10th, 12th, 14th, 15th and 17th days.
In contrast to this, parenchymal granuloma which characterizes the changes caused by virulent plague strains, was observed on the 4th, 9th, 11th and 13th days, in this experiment using EV. Granulomas appeared also in the Glissons' sheaths on the 3rd, 9th and 13th days. Necrosis was observed in the perivascular regions on the 10th, 13th, 14th and 15th days ; in the parenchyma, on the other hand, only the sections of 12th day showed this kind of change.
After the 16th day, the pathological changes in the liver showed subsidence.
The occasional presence of giant cells on the 6th, 11th and 14th days was noteworthy, though normal mice are known to have some megaloblasts in the spleen, whose morphology is similar to giant cells.
Spleen:
Strong proliferation of reticulum cells in the germinal centers was the common finding in the spleen on the 2nd to 18th days after the injection.
Besides, the germinal center showed strong hyperplasia on the 5th, 14th and 18th days. Especially, this was generalized on the 14th day.
Hyperplasia of follicles was found on the 2nd, 4th, 7th, 11th and 16th days. The changes on the 7th day was stronger than on the other days.
The changes in the red pulp were the increase in number of plasma cells and polymorphonuclear cells and the remarkable hyperplasia of reticular mesh on the 2nd day, a proliferation of reticulum cells and many proliferated splenocytes on the 6th day, a strong proliferation of reticulum cells on the 13th day and the same change in the pulp cord on the 17th day. On the 15th day the border between the red pulp and follicles was unclear and the reticulums of spleen pulp cords strongly proliferated.
Other findings in the spleen were hyperplasia of the adventitium of pinselar arteria on the 2nd day, many proliferated reticulum cells on the 3rd day, strong proliferation of reticulum cells on the 6th day, hyperaemia of the veins within the trabeculae on the 7th day, many proliferated splenocytes on the 8th day, strong hyperplasia and proliferation of splenocytes on the 11th day, hyperplasia and proliferation of reticulum cells and splenocytes on the 15th day and remarkable hyperplasia of many splenocytes on the 17th day. PLAGUE LIVE VACCINE AND MICE
DISCUSSION
Plague, one of the severest acute fatal infectious diseases, has not been completely controled in the world. It is known that the controls of rodents and fleas are the most radical countermeasures against plague. When these measures are not applicable for some reasons, we are urged to depend on the prophylactic immunization.
Prophylactic immunization against plague was reviewed in detail by Pollitzer (1954) and Meyer (1947) . According to them, live attenuated vaccines proved a limited prophylactic value at the time of epidemics between 1932 and 1940 in Java and Madagascar.
Kasuga (1940) also reported prophylactic effectiveness of an attenuated strain MIT 40 for prevention of plague in North-East China. Recent occurrence of thousands of cases in South Vietnam necessiated the Japanese authorities to establish an effective system counteracting the possible. accidental invasion from her neighbor countries.
From the ethical point of view, we can not inoculate human beings with any vaccine having even the least possibility to cause plague disease.
Virulence enhancement in human beings has never been reported during the massive prophylactic inoculation in Madagascar and other countries.
The authorities in the world, therefore, do not hisitate to use EV as a prophylactic live vaccine. Soviet standard dose for human inoculation is as large as 109 living bacilli (Korobkova, 1956) .
The most widely used live attenuated strain is EV, which was isolated and used for massive inoculation in Madagascar by Girard and Robic (1936) . This strain had become avirulent after subjected to monthly agar subculturing at 10-20 C for five years.
It then proved innocuous to guinea-pigs and rabbits upon percutaneous injection.
Subcutaneous injection into guinea-pigs was apt to produce a local induration which disappeared in about a week without involving the regional lymph-nodes.
In the case of guinea-pigs, we succeeded in decreasing such local induration to a negligible degree using smaller doses of around 10,000 bacilli conferring a complete protection against the challenge of 2,000 LD50 (unpublished data).
Pollitzer (1954) mentioned that mice and white rats, being toxin-sensitive, could not tolerate large doses of the EV but they were satisfactorily immunized with smaller doses. This was partially reconfirmed by our experiments (Fig. 2a) . In our experiments, however, the immunization was not satisfactory, because the doses larger than that protecting 60% of mice killed some mice during immunization by EV. Furthermore, our experiments uncovered another fact. The mice which tolerated the inoculation of 108 bacilli of the EV strain were protected against the challenging to a less extent than those receiving 107 EV (Fig. 2b) . This may be irreconcilable with the description of Pollitzer.
Since our EV was not transferred so many times after recovering from the lyophilized standard vaccine, the discrepancy from the description of Pollitzer may be attributable to the different strains of mice rather than to the mutation of the bacterial strain.
Less extent of protection afforded by vaccination with larger dose reminds us of the phenomenon of immunounresponsiveness in which an excessive amount of antigen inhibits the production of antibody. Spivack et al. (1958) and Walker (1962) reported the immunounresponsiveness of guinea pigs to high concentrations of Pasteurella pestis Fraction I. Nobody has reported a similar phenomenon oc- MORITA et al. Vol. 23 curring in mice. Another explanation of our finding is the possibility that live EV destroys the organ or tissue playing an important role in immune responses. The experiment shown in Fig. 1 suggested such a possibility by proving the invasion of some of living EV into the spleen and liver. It also proved the survival of EV within the host organs for at least one week. The histopathological changs described in this report support these explanations.
The fact that subcutaneous injection of some millions of EV into mice produced such clear histopathological changes in the internal organs of the host urged us to clarify the mechanisms and differentiate them from the virulence-enhancing mechanisms of the virulent strain.
The discussion explaining the extremely small number of viable EV detected in the internal organs as compared with the number of the microscopic changes in the liver and spleen, will follow later in this section.
This point of our interest has arisen from the finding of Jackson and Burrows (1956) that iron has a virulence-enhancing effect on EV in mice. More detailed studies on this phenomenon are under way in our laboratory.
It was necessary to characterize the histopathological changes in the mouse organs caused by EV alone to compare with those caused by toxin, the virulent strain and EV plus iron.
By the above-mentioned discussion, the record of the histopathological findings in the mouse organs, injected with as large a dose of EV strain as will be suitable for vaccination of mice, will serve as a basis for further studies. Histopathological changes were found mostly in the lungs, liver and spleen.
No change was found in the sections from normal mice of the same lot under the same conditions. The changes began to appear in the liver from the next day after subcutaneous injection.
Their severity and the number of lesions increased gradually and then persisted up to the 18th day when the observation terminated.
The experiment shown in Fig. 1 detected the live EV up to the 5-8th day after injection at the injected site, up to the 3rd day in the liver, and till the 5th day in the spleen. The period of maintenance of live bacilli may be changeable depending on the inoculation dose and individual mouse. The histopathological changes, however, were detectable for a much longer period than that of the maintenance of live bacilli. It is conceivable that these changes were the reactions to not only live bacilli but also to dead bacterial bodies or their components including murine toxin. To summarize these histopathological findings, remarkable changes were scarcely detectable in the lungs, except slight scattering of peribronchial connective tissues, perivascular cell infiltration and hyperplasia of alveolar epithelial cells on the sections of the 4th, 10th and 16th days after injection.
Because these changes were not detected continuously, it is more reasonable to think them not to be specific to the action of EV, though the reversal interpretation can not be excluded, because no such change was detected in the control mice under the same condition.
The changes in the liver were severe and characteristic to the injected mice. Most common changes were cellular infiltration in the liver parenchyma, Glissons' sheaths and perivascular regions.
We detected proliferation of granulomas in the parenchyma and perivascular regions on the sections of the 3rd, 4th, 9th, 10th, 11th, 12th, 13th, 14th, 15th and 17th days after injection. Perivascular necrosis was found on the sections of the 4th, 6th, 10th, 12th, 13th, 14th and 15th days after injection. Other changes were hyperplasia of Kuppfers' cells, proliferation of liver capsule and hyperaemia and subcapsular fatty degera-
